31309015|t|Lithium-induced Hyperparathyroidism and Hypercalcemia.
31309015|a|Lithium is one of the mainstays of treatment for bipolar disorder. Chronic lithium therapy can rarely lead to hypercalcemia secondary to lithium-induced hyperparathyroidism. We present a 66-year-old female patient with bipolar disorder on lithium therapy presenting with hypercalcemia. We discussed the pathophysiology and management of hyperparathyroidism and hypercalcemia in patients on chronic lithium therapy.
31309015	0	7	Lithium	Chemical	MESH:D008094
31309015	16	35	Hyperparathyroidism	Disease	MESH:D006961
31309015	40	53	Hypercalcemia	Disease	MESH:D006934
31309015	55	62	Lithium	Chemical	MESH:D008094
31309015	104	120	bipolar disorder	Disease	MESH:D001714
31309015	130	137	lithium	Chemical	MESH:D008094
31309015	165	178	hypercalcemia	Disease	MESH:D006934
31309015	192	199	lithium	Chemical	MESH:D008094
31309015	208	227	hyperparathyroidism	Disease	MESH:D006961
31309015	261	268	patient	Species	9606
31309015	274	290	bipolar disorder	Disease	MESH:D001714
31309015	294	301	lithium	Chemical	MESH:D008094
31309015	326	339	hypercalcemia	Disease	MESH:D006934
31309015	392	411	hyperparathyroidism	Disease	MESH:D006961
31309015	416	429	hypercalcemia	Disease	MESH:D006934
31309015	433	441	patients	Species	9606
31309015	453	460	lithium	Chemical	MESH:D008094
31309015	Negative_Correlation	MESH:D008094	MESH:D001714
31309015	Positive_Correlation	MESH:D008094	MESH:D006961
31309015	Positive_Correlation	MESH:D008094	MESH:D006934

